VirExit Technologies

VirExit Technologies Current Assets

Current Assets of VirExit Technologies (VXIT) as of Nov 4, 2026.

Current Assets

0.00USD

Last updated:

Current Assets of VirExit Technologies is 2025 0.00 USD. Current Assets of VirExit Technologies was 2024 60,000.00 USD. It decreases by % lower compared to the previous year.

The VirExit Technologies Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
24,177.00 USD
Jan 1, 2019
89,523.00 USD
Jan 1, 2020
48,334.00 USD
Jan 1, 2021
1,697.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
10,120.00 USD
Jan 1, 2024
60,000.00 USD
Jan 1, 2025
0.00 USD
The VirExit Technologies Current Assets history
YEARCurrent AssetsYoY
0.00USD-100.00%
60,000.00USD+492.89%
10,120.00USD—
0.00USD-100.00%
1,697.00USD-96.49%
48,334.00USD-46.01%
89,523.00USD+270.28%
24,177.00USD-9.11%
26,600.00USD-83.22%
158,513.00USD+80.68%
87,731.00USD-43.42%
155,059.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

VirExit Technologies Stock analysis

What does VirExit Technologies do? VirExit Technologies, Inc. generates revenue through its branded products and services, including disinfectant cleaners, antiviral medications, personal protective equipment (PPE), and sterilization systems under the VirExit(r) and VirExit.com brands. The company targets buyers seeking protective solutions for individual, community, and local economic needs in rural and peri-urban areas globally. Its Lexian product, an Ultraviolet-C-based device, is marketed as a sterilization system for disabling viruses and bacteria through optical diffusion. The firm operates a vertical online marketplace as a primary sales and marketing platform, connecting buyers and sellers of protective products and services. This platform serves as a single source for customers requiring disinfectants, medications, PPE, and sterilization systems. VirExit(r) and VirExit.com are the key brands driving product visibility and sales across its target segments. VirExit Technologies focuses on rural and peri-urban markets worldwide, where it incubates franchise business concepts to support local economies. The company's offerings are designed to address health and safety needs, with Lexian positioned as a specialized sterilization solution. Its business model integrates product sales, franchise incubation, and an online marketplace to serve both individual and community-level demand. VirExit Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about VirExit Technologies stock

On Eulerpool you can find the complete historical development of Current Assets VirExit Technologies since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's VirExit Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — VirExit Technologies

All Key Metrics — VirExit Technologies